Menu

2023 Using Principles of Drug Standardization to Promote Patient Safety

  • Claim Credits by 12/19/2025
  • Online Activity
Credits Available: CME, Patient Safety, Quality Improvement (Part 4)

Through this education program, anesthesiologists and other participants will learn the benefits of local drug concentration standardization in protecting patient safety during transitions of care and drug administration. Participants will...  Read More +




Item Details

The American Society of Anesthesiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Anesthesiologists designates this enduring material activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity contributes to the patient safety CME requirement for the CME component of the American Board of Anesthesiology’s (ABA) redesigned Maintenance of Certification in Anesthesiology® (MOCA®) program.

This activity contributes to the Quality Improvement component of the American Board of Anesthesiology’s (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®). Earn up to 1.5 points for completion of the activity.

  • Identify how multiple drug concentrations pose a medication safety risk to patients in inpatient and outpatient settings, especially during transfers of care.
  • Discuss strategies for reducing the number of drug concentrations available for surgical and procedural operations.
  • Discuss the use of ready to administer manufacturer prepared pre-filled syringes in the operating room and how such syringes may improve patient safety (including patient safety concerned with opioid administration), reduce opportunities for errors, and reduce medication waste.
  • Apply principles of drug standardization to identify three drugs within the learner’s facility that could benefit from a limited set of concentrations for medications. Such medications have been labeled as high-alert or known to have produced a significant number of adverse events.
Anesthesiologists, Certified Registered Nurse Anesthetists, Certified Anesthesiology Assistants, and Hospital and Health-System Pharmacists

Dr. Monica Harbell is an Assistant Professor in the Department of Anesthesiology and Perioperative Medicine at the Mayo Clinic in Phoenix, AZ.

Dr. Elizabeth Rebello is Professor of Anesthesiology and Perioperative Medicine at the University of Texas MD Anderson Cancer Center.

Dr. Navil F. Sethna is Clinical Director of the Pediatric Pain Rehabilitation Center and Senior Associate in Pain Medicine and Perioperative Anesthesia within the Department of Anesthesiology, Critical Care and Pain Medicine at Boston Children’s Hospital.

Dr. Nathaniel Sims is the Newbower/Eitan MGH Endowed Chair in Biomedical Technology Innovation within the Department of Anesthesia, Clinical Care and Pain Medicine at Massachusetts General Hospital.

The American Society of Anesthesiologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Society of Anesthesiologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Society of Anesthesiologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Society of Anesthesiologists educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Society of Anesthesiologists education activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Dr. Monica Harbell, Dr. Elizabeth Rebello, and Dr. Navil Sethna have disclosed no relevant financial relationships with ineligible companies.

Dr. Nathaniel Sims has disclosed a financial relationship with Baxter Pharmaceuticals.

Internet connection, web browser version must have been released within the last three years.
2023 Using Principles of Drug Standardization to Promote Patient Safety
  • Non-member Price: Free